Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MIS: Challenges in an Evolving Market

Executive Summary

Technology and techniques for minimally invasive surgery continue to evolve as medical device manufacturers and clinicians alike look for ways to further minimize the invasiveness, pain, and scarring associated with surgery. At the same time, the economy and health care reform have created challenges for medical device manufacturers. In response to these challenges, mannufacturers competing in the MIS market are developing new products and marketing strategies designed to ease both the economic and environmental impact for providers.

Related Content

Teleflex Bets Percutaneous Laparoscopy Will Be MIS Game Changer
Covidien’s Project ADOPT: Moving The Needle On MIS
Hernia Repair: No Simple Solution
Trends In MIS, Part I: Pushing Surgical Boundaries
New Directions for Robotic Surgery
What's Next for NOTES? An Interview with Santiago Horgan, MD
Single-Incision Laparoscopy: Boon or Bust?
Single-Incision Laparoscopy: Boon or Bust?
Intuitive Surgical: Making Robotics Real


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts